Mirabegron (25mg)+ Solifenacin (5mg)
Bladmir-S 25 Tablet ER is advised to be taken in the dose and duration as prescribed by your doctor. It may be taken with or without food, preferably at the same time each day. You should not stop taking the medicine without consulting the doctor as it may lead to the worsening of your symptoms. The course of the treatment should be completed for better efficacy of the medicine.Some of the common side effects of this medicine are hypertension (high blood pressure), nasopharyngitis (inflammation of the throat and nasal passages), urinary tract infection, and headache. If any of the side effects bother you or persist, consult the doctor without delay.Before receiving the treatment, inform your doctor if you are on any medication for any other health condition. If you are pregnant or breastfeeding, tell your doctor prior to the treatment. People with liver or kidney disease must be cautious while receiving the prescription and they must receive regular follow-ups as per the doctor’s advice.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of Bladmir-S
10 tablet er
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Bladmir-S 25 Tablet ER may be taken with or without food, but it is better to take it at a fixed time.
Bladmir-S 25 Tablet ER is a combination of two medicines: Mirabegron and Solifenacin. Mirabegron is a beta 3-receptor agonist. It works by activating the receptor in the bladder, causing the bladder muscles to relax. Solifenacin is an antimuscarinic. It also works by relaxing muscles of the urinary bladder. In this way, it works to prevent frequent, urgent, or uncontrolled urge of urination.
Related Warnings
Caution is advised when consuming alcohol with Bladmir-S 25 Tablet ER. Please consult your doctor.
Information regarding the use of Bladmir-S 25 Tablet ER during pregnancy is not available. Please consult your doctor.
Information regarding the use of Bladmir-S 25 Tablet ER during breastfeeding is not available. Please consult your doctor.
It is not known whether Bladmir-S 25 Tablet ER alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
There is limited information available on the use of Bladmir-S 25 Tablet ER in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Bladmir-S 25 Tablet ER in patients with liver disease. Please consult your doctor.
null
